In Vitro Diagnostics (IVD) Products and Test
In Vitro Diagnostics (IVD) Products and Test market is segmented by players, region (country), by ... Read More
Global Next Generation Cancer Diagnostic Devices Market Research Report 2024
1 Next Generation Cancer Diagnostic Devices Market Overview
1.1 Product Overview and Scope of Next Generation Cancer Diagnostic Devices
1.2 Next Generation Cancer Diagnostic Devices Segment by Type
1.2.1 Global Next Generation Cancer Diagnostic Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 Lab-on- a- chip (LOAC)
1.2.5 Protein Microarrays
1.2.6 DNA Microarrays
1.2.7 Reverse Transcriptase-PCR (RT-PCR)
1.3 Next Generation Cancer Diagnostic Devices Segment by Application
1.3.1 Global Next Generation Cancer Diagnostic Devices Sales Comparison by Application: (2022-2028)
1.3.2 Biomarker Development
1.3.3 CTC Analysis
1.3.4 Proteomic Analysis
1.3.5 Epigenetic Analysis
1.3.6 Genetic Analysis
1.4 Global Next Generation Cancer Diagnostic Devices Market Size Estimates and Forecasts
1.4.1 Global Next Generation Cancer Diagnostic Devices Revenue 2017-2028
1.4.2 Global Next Generation Cancer Diagnostic Devices Sales 2017-2028
1.4.3 Next Generation Cancer Diagnostic Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Next Generation Cancer Diagnostic Devices Market Competition by Manufacturers
2.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Next Generation Cancer Diagnostic Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Next Generation Cancer Diagnostic Devices Manufacturing Sites, Area Served, Product Type
2.5 Next Generation Cancer Diagnostic Devices Market Competitive Situation and Trends
2.5.1 Next Generation Cancer Diagnostic Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Next Generation Cancer Diagnostic Devices Players Market Share by Revenue
2.5.3 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Next Generation Cancer Diagnostic Devices Retrospective Market Scenario by Region
3.1 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
3.3.1 North America Next Generation Cancer Diagnostic Devices Sales by Country
3.3.2 North America Next Generation Cancer Diagnostic Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
3.4.1 Europe Next Generation Cancer Diagnostic Devices Sales by Country
3.4.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Next Generation Cancer Diagnostic Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Region
3.5.2 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
3.6.1 Latin America Next Generation Cancer Diagnostic Devices Sales by Country
3.6.2 Latin America Next Generation Cancer Diagnostic Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Country
3.7.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Next Generation Cancer Diagnostic Devices Historic Market Analysis by Type
4.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2017-2022)
4.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2017-2022)
4.3 Global Next Generation Cancer Diagnostic Devices Price by Type (2017-2022)
5 Global Next Generation Cancer Diagnostic Devices Historic Market Analysis by Application
5.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2017-2022)
5.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2017-2022)
5.3 Global Next Generation Cancer Diagnostic Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Roche Holding Ltd.（Switzerland)
6.1.1 Roche Holding Ltd.（Switzerland) Corporation Information
6.1.2 Roche Holding Ltd.（Switzerland) Description and Business Overview
6.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product Portfolio
6.1.5 Roche Holding Ltd.（Switzerland) Recent Developments/Updates
6.2 Abbott Laboratories(US)
6.2.1 Abbott Laboratories(US) Corporation Information
6.2.2 Abbott Laboratories(US) Description and Business Overview
6.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Portfolio
6.2.5 Abbott Laboratories(US) Recent Developments/Updates
6.3 Siemens Healthcare(Germany)
6.3.1 Siemens Healthcare(Germany) Corporation Information
6.3.2 Siemens Healthcare(Germany) Description and Business Overview
6.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Portfolio
6.3.5 Siemens Healthcare(Germany) Recent Developments/Updates
6.4 Agilent Technologies Inc(Germany)
6.4.1 Agilent Technologies Inc(Germany) Corporation Information
6.4.2 Agilent Technologies Inc(Germany) Description and Business Overview
6.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Portfolio
6.4.5 Agilent Technologies Inc(Germany) Recent Developments/Updates
6.5 Illumina Inc.(US)
6.5.1 Illumina Inc.(US) Corporation Information
6.5.2 Illumina Inc.(US) Description and Business Overview
6.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product Portfolio
6.5.5 Illumina Inc.(US) Recent Developments/Updates
6.6 Becton Dickinson and Co.(US)
6.6.1 Becton Dickinson and Co.(US) Corporation Information
6.6.2 Becton Dickinson and Co.(US) Description and Business Overview
6.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Portfolio
6.6.5 Becton Dickinson and Co.(US) Recent Developments/Updates
6.7 QIAGEN N.V.(Germany)
6.6.1 QIAGEN N.V.(Germany) Corporation Information
6.6.2 QIAGEN N.V.(Germany) Description and Business Overview
6.6.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Portfolio
6.7.5 QIAGEN N.V.(Germany) Recent Developments/Updates
6.8 Affymetrix Inc.(US)
6.8.1 Affymetrix Inc.(US) Corporation Information
6.8.2 Affymetrix Inc.(US) Description and Business Overview
6.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Portfolio
6.8.5 Affymetrix Inc.(US) Recent Developments/Updates
6.9 Johnson & Johnson(US)
6.9.1 Johnson & Johnson(US) Corporation Information
6.9.2 Johnson & Johnson(US) Description and Business Overview
6.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Portfolio
6.9.5 Johnson & Johnson(US) Recent Developments/Updates
6.10 Thermo Fisher Scientific Inc.(US)
6.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
6.10.2 Thermo Fisher Scientific Inc.(US) Description and Business Overview
6.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Portfolio
6.10.5 Thermo Fisher Scientific Inc.(US) Recent Developments/Updates
6.11 GE Healthcare(England)
6.11.1 GE Healthcare(England) Corporation Information
6.11.2 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product Portfolio
6.11.5 GE Healthcare(England) Recent Developments/Updates
6.12 Life Technologies Corp.(US)
6.12.1 Life Technologies Corp.(US) Corporation Information
6.12.2 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product Portfolio
6.12.5 Life Technologies Corp.(US) Recent Developments/Updates
6.13 Luminex Corp.(US)
6.13.1 Luminex Corp.(US) Corporation Information
6.13.2 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product Portfolio
6.13.5 Luminex Corp.(US) Recent Developments/Updates
6.14 Cepheid Inc.(US)
6.14.1 Cepheid Inc.(US) Corporation Information
6.14.2 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product Portfolio
6.14.5 Cepheid Inc.(US) Recent Developments/Updates
6.15 Allegro Diagnostics Corp.(Brazil)
6.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
6.15.2 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product Portfolio
6.15.5 Allegro Diagnostics Corp.(Brazil) Recent Developments/Updates
7 Next Generation Cancer Diagnostic Devices Manufacturing Cost Analysis
7.1 Next Generation Cancer Diagnostic Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
7.4 Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Next Generation Cancer Diagnostic Devices Distributors List
8.3 Next Generation Cancer Diagnostic Devices Customers
9 Next Generation Cancer Diagnostic Devices Market Dynamics
9.1 Next Generation Cancer Diagnostic Devices Industry Trends
9.2 Next Generation Cancer Diagnostic Devices Market Drivers
9.3 Next Generation Cancer Diagnostic Devices Market Challenges
9.4 Next Generation Cancer Diagnostic Devices Market Restraints
10 Global Market Forecast
10.1 Next Generation Cancer Diagnostic Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Next Generation Cancer Diagnostic Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Next Generation Cancer Diagnostic Devices by Type (2023-2028)
10.2 Next Generation Cancer Diagnostic Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Next Generation Cancer Diagnostic Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Next Generation Cancer Diagnostic Devices by Application (2023-2028)
10.3 Next Generation Cancer Diagnostic Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Next Generation Cancer Diagnostic Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Next Generation Cancer Diagnostic Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Next Generation Cancer Diagnostic Devices Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Next Generation Cancer Diagnostic Devices Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Next Generation Cancer Diagnostic Devices Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Next Generation Cancer Diagnostic Devices Market Competitive Situation by Manufacturers in 2021
Table 5. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Next Generation Cancer Diagnostic Devices Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Next Generation Cancer Diagnostic Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Next Generation Cancer Diagnostic Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Next Generation Cancer Diagnostic Devices Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2017-2022)
Table 17. Global Next Generation Cancer Diagnostic Devices Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2017-2022)
Table 19. North America Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2017-2022)
Table 21. North America Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2017-2022)
Table 23. Europe Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2017-2022)
Table 25. Europe Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2017-2022)
Table 31. Latin America Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2017-2022)
Table 33. Latin America Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2017-2022)
Table 39. Global Next Generation Cancer Diagnostic Devices Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2017-2022)
Table 41. Global Next Generation Cancer Diagnostic Devices Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2017-2022)
Table 43. Global Next Generation Cancer Diagnostic Devices Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2017-2022)
Table 45. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2017-2022)
Table 46. Global Next Generation Cancer Diagnostic Devices Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Next Generation Cancer Diagnostic Devices Revenue Share by Application (2017-2022)
Table 48. Global Next Generation Cancer Diagnostic Devices Price by Application (2017-2022) & (USD/Pcs)
Table 49. Roche Holding Ltd.（Switzerland) Corporation Information
Table 50. Roche Holding Ltd.（Switzerland) Description and Business Overview
Table 51. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product
Table 53. Roche Holding Ltd.（Switzerland) Recent Developments/Updates
Table 54. Abbott Laboratories(US) Corporation Information
Table 55. Abbott Laboratories(US) Description and Business Overview
Table 56. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product
Table 58. Abbott Laboratories(US) Recent Developments/Updates
Table 59. Siemens Healthcare(Germany) Corporation Information
Table 60. Siemens Healthcare(Germany) Description and Business Overview
Table 61. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product
Table 63. Siemens Healthcare(Germany) Recent Developments/Updates
Table 64. Agilent Technologies Inc(Germany) Corporation Information
Table 65. Agilent Technologies Inc(Germany) Description and Business Overview
Table 66. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product
Table 68. Agilent Technologies Inc(Germany) Recent Developments/Updates
Table 69. Illumina Inc.(US) Corporation Information
Table 70. Illumina Inc.(US) Description and Business Overview
Table 71. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 73. Illumina Inc.(US) Recent Developments/Updates
Table 74. Becton Dickinson and Co.(US) Corporation Information
Table 75. Becton Dickinson and Co.(US) Description and Business Overview
Table 76. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product
Table 78. Becton Dickinson and Co.(US) Recent Developments/Updates
Table 79. QIAGEN N.V.(Germany) Corporation Information
Table 80. QIAGEN N.V.(Germany) Description and Business Overview
Table 81. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product
Table 83. QIAGEN N.V.(Germany) Recent Developments/Updates
Table 84. Affymetrix Inc.(US) Corporation Information
Table 85. Affymetrix Inc.(US) Description and Business Overview
Table 86. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 88. Affymetrix Inc.(US) Recent Developments/Updates
Table 89. Johnson & Johnson(US) Corporation Information
Table 90. Johnson & Johnson(US) Description and Business Overview
Table 91. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product
Table 93. Johnson & Johnson(US) Recent Developments/Updates
Table 94. Thermo Fisher Scientific Inc.(US) Corporation Information
Table 95. Thermo Fisher Scientific Inc.(US) Description and Business Overview
Table 96. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 98. Thermo Fisher Scientific Inc.(US) Recent Developments/Updates
Table 99. GE Healthcare(England) Corporation Information
Table 100. GE Healthcare(England) Description and Business Overview
Table 101. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product
Table 103. GE Healthcare(England) Recent Developments/Updates
Table 104. Life Technologies Corp.(US) Corporation Information
Table 105. Life Technologies Corp.(US) Description and Business Overview
Table 106. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 107. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 108. Life Technologies Corp.(US) Recent Developments/Updates
Table 109. Luminex Corp.(US) Corporation Information
Table 110. Luminex Corp.(US) Description and Business Overview
Table 111. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 113. Luminex Corp.(US) Recent Developments/Updates
Table 114. Cepheid Inc.(US) Corporation Information
Table 115. Cepheid Inc.(US) Description and Business Overview
Table 116. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 118. Cepheid Inc.(US) Recent Developments/Updates
Table 119. Allegro Diagnostics Corp.(Brazil) Corporation Information
Table 120. Allegro Diagnostics Corp.(Brazil) Description and Business Overview
Table 121. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product
Table 123. Allegro Diagnostics Corp.(Brazil) Recent Developments/Updates
Table 124. Production Base and Market Concentration Rate of Raw Material
Table 125. Key Suppliers of Raw Materials
Table 126. Next Generation Cancer Diagnostic Devices Distributors List
Table 127. Next Generation Cancer Diagnostic Devices Customers List
Table 128. Next Generation Cancer Diagnostic Devices Market Trends
Table 129. Next Generation Cancer Diagnostic Devices Market Drivers
Table 130. Next Generation Cancer Diagnostic Devices Market Challenges
Table 131. Next Generation Cancer Diagnostic Devices Market Restraints
Table 132. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2023-2028) & (K Pcs)
Table 133. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Type (2023-2028)
Table 134. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 135. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Type (2023-2028)
Table 136. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2023-2028) & (K Pcs)
Table 137. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Application (2023-2028)
Table 138. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 139. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Application (2023-2028)
Table 140. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Region (2023-2028) & (K Pcs)
Table 141. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Region (2023-2028)
Table 142. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 143. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Region (2023-2028)
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Next Generation Cancer Diagnostic Devices
Figure 2. Global Next Generation Cancer Diagnostic Devices Market Share by Type in 2021 & 2028
Figure 3. Next Generation Sequencing Product Picture
Figure 4. qPCR & Multiplexing Product Picture
Figure 5. Lab-on- a- chip (LOAC) Product Picture
Figure 6. Protein Microarrays Product Picture
Figure 7. DNA Microarrays Product Picture
Figure 8. Reverse Transcriptase-PCR (RT-PCR) Product Picture
Figure 9. Global Next Generation Cancer Diagnostic Devices Market Share by Application in 2021 & 2028
Figure 10. Biomarker Development
Figure 11. CTC Analysis
Figure 12. Proteomic Analysis
Figure 13. Epigenetic Analysis
Figure 14. Genetic Analysis
Figure 15. Global Next Generation Cancer Diagnostic Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Next Generation Cancer Diagnostic Devices Market Size (2017-2028) & (US$ Million)
Figure 17. Global Next Generation Cancer Diagnostic Devices Sales (2017-2028) & (K Pcs)
Figure 18. Next Generation Cancer Diagnostic Devices Sales Share by Manufacturers in 2021
Figure 19. Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers in 2021
Figure 20. The Global 5 and 10 Largest Next Generation Cancer Diagnostic Devices Players: Market Share by Revenue in 2021
Figure 21. Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2017-2022)
Figure 23. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region in 2021
Figure 24. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2017-2022)
Figure 25. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region in 2021
Figure 26. U.S. Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Canada Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Germany Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. France Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. U.K. Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Italy Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Russia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Japan Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. South Korea Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. India Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Australia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Taiwan Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Indonesia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Thailand Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Malaysia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Philippines Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Vietnam Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Mexico Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Brazil Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Argentina Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Turkey Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Saudi Arabia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. U.A.E Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 50. Sales Market Share of Next Generation Cancer Diagnostic Devices by Type (2017-2022)
Figure 51. Manufacturing Cost Structure of Next Generation Cancer Diagnostic Devices
Figure 52. Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
Figure 53. Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Holding Ltd.（Switzerland) Abbott Laboratories(US) Siemens Healthcare(Germany) Agilent Technologies Inc(Germany) Illumina Inc.(US) Becton Dickinson and Co.(US) QIAGEN N.V.(Germany) Affymetrix Inc.(US) Johnson & Johnson(US) Thermo Fisher Scientific Inc.(US) GE Healthcare(England) Life Technologies Corp.(US) Luminex Corp.(US) Cepheid Inc.(US) Allegro Diagnostics Corp.(Brazil)